These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34132694)

  • 1. Patient-reported Outcomes After Metabolic Surgery Versus Medical Therapy for Diabetes: Insights From the STAMPEDE Randomized Trial.
    Aminian A; Kashyap SR; Wolski KE; Brethauer SA; Kirwan JP; Nissen SE; Bhatt DL; Schauer PR
    Ann Surg; 2021 Sep; 274(3):524-532. PubMed ID: 34132694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INCREASED BONE TURNOVER IN TYPE 2 DIABETES PATIENTS RANDOMIZED TO BARIATRIC SURGERY VERSUS MEDICAL THERAPY AT 5 YEARS.
    Crawford MR; Pham N; Khan L; Bena JF; Schauer PR; Kashyap SR
    Endocr Pract; 2018 Mar; 24(3):256-264. PubMed ID: 29144812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.
    Malin SK; Samat A; Wolski K; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
    Int J Obes (Lond); 2014 Mar; 38(3):364-70. PubMed ID: 24166065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery for weight loss in adults.
    Colquitt JL; Pickett K; Loveman E; Frampton GK
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003641. PubMed ID: 25105982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMPACT OF WEIGHT LOSS TRAJECTORY FOLLOWING RANDOMIZATION TO BARIATRIC SURGERY ON LONG-TERM DIABETES GLYCEMIC AND CARDIOMETABOLIC PARAMETERS.
    Zhou K; Wolski K; Malin SK; Aminian A; Schauer PR; Bhatt DL; Kashyap SR
    Endocr Pract; 2019 Jun; 25(6):572-579. PubMed ID: 30865529
    [No Abstract]   [Full Text] [Related]  

  • 6. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.
    Schauer PR; Bhatt DL; Kirwan JP; Wolski K; Aminian A; Brethauer SA; Navaneethan SD; Singh RP; Pothier CE; Nissen SE; Kashyap SR;
    N Engl J Med; 2017 Feb; 376(7):641-651. PubMed ID: 28199805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of revisional bariatric surgery on type 2 diabetes mellitus.
    Aleassa EM; Hassan M; Hayes K; Brethauer SA; Schauer PR; Aminian A
    Surg Endosc; 2019 Aug; 33(8):2642-2648. PubMed ID: 30341657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy.
    Nielsen HJ; Nedrebø BG; Fosså A; Andersen JR; Assmus J; Dagsland VH; Dankel SN; Gudbrandsen OA; Fernø J; Hjellestad I; Hjermstad MJ; Kolotkin RL; Thorsen HL; Mellgren G; Flølo TN
    Int J Obes (Lond); 2022 Apr; 46(4):739-749. PubMed ID: 34974544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.
    Schauer PR; Bhatt DL; Kirwan JP; Wolski K; Brethauer SA; Navaneethan SD; Aminian A; Pothier CE; Kim ES; Nissen SE; Kashyap SR;
    N Engl J Med; 2014 May; 370(21):2002-13. PubMed ID: 24679060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of Type 2 Diabetes Mellitus (T2DM) after Sleeve Gastrectomy (SG), One-Anastomosis Gastric Bypass (OAGB), and Roux-en-Y Gastric Bypass (RYGB): A Systematic Review.
    Balasubaramaniam V; Pouwels S
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241216
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study.
    McTigue KM; Wellman R; Nauman E; Anau J; Coley RY; Odor A; Tice J; Coleman KJ; Courcoulas A; Pardee RE; Toh S; Janning CD; Williams N; Cook A; Sturtevant JL; Horgan C; Arterburn D;
    JAMA Surg; 2020 May; 155(5):e200087. PubMed ID: 32129809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment.
    Kashyap SR; Bhatt DL; Wolski K; Watanabe RM; Abdul-Ghani M; Abood B; Pothier CE; Brethauer S; Nissen S; Gupta M; Kirwan JP; Schauer PR
    Diabetes Care; 2013 Aug; 36(8):2175-82. PubMed ID: 23439632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes.
    Heshmati K; Harris DA; Aliakbarian H; Tavakkoli A; Sheu EG
    Surg Obes Relat Dis; 2019 Dec; 15(12):2025-2032. PubMed ID: 31711946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in quality of life after bariatric surgery: sleeve versus bypass.
    Versteegden DPA; Van Himbeeck MJJ; Nienhuijs SW
    Surg Obes Relat Dis; 2018 Feb; 14(2):170-174. PubMed ID: 29150392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy.
    Maghrabi AH; Wolski K; Abood B; Licata A; Pothier C; Bhatt DL; Nissen S; Brethauer SA; Kirwan JP; Schauer PR; Kashyap SR
    Obesity (Silver Spring); 2015 Dec; 23(12):2344-8. PubMed ID: 26193177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleeve gastrectomy and Roux-en-Y gastric bypass in the treatment of type 2 diabetes. Two-year results from a Swedish multicenter randomized controlled trial.
    Wallenius V; Alaraj A; Björnfot N; Orrenius B; Kylebäck A; Björklund P; Werling M; Thorell A; Fändriks L; Maleckas A
    Surg Obes Relat Dis; 2020 Aug; 16(8):1035-1044. PubMed ID: 32540150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study.
    Moradi M; Kabir A; Khalili D; Lakeh MM; Dodaran MS; Pazouki A; Kermansaravi M; Alibeigi P; Moazenzadeh H; Abdolhosseini MR; Eghbali F; Baradaran HR
    BMC Endocr Disord; 2022 Oct; 22(1):260. PubMed ID: 36289529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities.
    Ruiz-Tovar J; Carbajo MA; Jimenez JM; Castro MJ; Gonzalez G; Ortiz-de-Solorzano J; Zubiaga L
    Surg Endosc; 2019 Feb; 33(2):401-410. PubMed ID: 29943058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bariatric surgery or medicine for type 2 diabetes?
    Doggrell SA; Chan V
    Expert Opin Pharmacother; 2012 Oct; 13(15):2249-53. PubMed ID: 22957791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirty-day outcomes of sleeve gastrectomy versus Roux-en-Y gastric bypass: first report based on Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database.
    Chaar ME; Lundberg P; Stoltzfus J
    Surg Obes Relat Dis; 2018 May; 14(5):545-551. PubMed ID: 29551470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.